In the world of biochemistry and peptide research, few molecules command as much fascination as the cyclosporine structure. As someone deeply involved in the study of peptide synthesis and structural biology, I have spent significant time analyzing the cyclosporine peptide sequence. It is not merely a string of amino acids; it is a masterpiece of non-ribosomal synthesis that challenges our understanding of molecular architecture.
The Structural Complexity of Cyclosporin A
When we look a Cyclosporins are natural or synthetic undecapeptideswith a wide range of actual and potential pharmaceutical applications.Read more t the cyclosporin A molecule, we are observing an 11-residue N-C macrocyclic peptide. What makes this molecule truly unique is its non-ribosomal origin. Unlike standard proteins built by ribosomes, this molecule is synthesized by a massive enzyme complex known as nonribo structure, pharmacokinetics, and therapeutic drug monitoring - PubMed somal peptide synthetase, cyclosporin synthetase. This enzyme, which has a molecular mass of approximately 800 kDa, is one of the most complex peptide-synthesizing machines identified in nature.
From my own experience in laboratory settings, understanding the sequence is vital for those interested in the synthesis of cyclic compounds. The primary sequence is generally identified as:
*cyclo[Abu-Sar-N(Me)Leu-Val-N(Me)Leu-Ala-D-Ala- Cyclosporin A is an 11 residue N-C macrocyclic peptide. Seven peptide bonds are N-methylated (highlighted in blue). Two residues possess non-proteinogenic Read more N(Me)Leu-N(Me)Leu-N(Me)Val-Bmt]*
This arrangement highlights that cyclosporins are natural or synthetic undecapeptides. The presence of non-proteinogenic amino acids, such as (4R)-4-[(E)-2-butyl]-4-methyl-L-threonine (Bmt), is what grants the molecule its distinct chemical properties.
Analyzing the Macrocyclic Nature
The term polypeptide chains which contain a circular sequence of bonds perfectly de 1IKF: A CONFORMATION OF CYCLOSPORIN A IN scribes the structural integrity of this molecule. Because it is a cyclic nonribosomal peptide of eleven amino acids, it lacks the free N- and C-termini found in linear proteins.
During my research into the cyclosporin A structure, I found it fascinating that cyclosporin itself has a cis-peptide bond between specific residues, which contributes to its unique folding pattern. Furthermore, the molecule acts as an 11 residue N-C macrocyclic peptide, where seven of the peptide by J Dittmann·1994·Cited by 116—Four intermediate peptides of the growing peptide chain of cyclosporin Acould be isolated and identified. All of them represent partial sequences of Read more bonds are N-methylated. This methylation is a critical factor in its lipophilicity and its ability to act as a nonpolar cyclic peptide.
Insights into Synthesis and Research
When discussing the cyclosporin A peptide, it is important to acknowledge that this is a specialized area of study. In laboratory environments, researchers often investigate the four intermediate peptides of the growing peptide chain of cyclosporin A to better understand how the synthetase enzyme functions.
Many variations exist, such as [Ala] 2 -, [Thr] 2 -, [Val] 2 -, and [D-MeVal] 11- cyclosporin. These derivatives are essential for mapping the structure-activity relationship. Whether you are loo CAS 59865-13-3 (Cyclosporin A) king at the amino acid sequence for computational modeling or physical synthesis, the complexity of the eight-stranded antiparallel beta-barrel structure of the associated binding proteins, like cyclophilin, provides a broader context for why this peptide is so highly studied in biochemistry.
Prac Cyclosporin A peptide tical Considerations for Researchers
For those exploring this field, it is important to distinguish between the various forms of the molecule. Cyclosporin A is frequently utilized in specialized research due to its interaction with cellular targets. It functions as a calcineurin inhibitor, a mechanism that has been mapped through the crystal structure of calcineurin-cyclophilin-cyclosporin complexes.
If you are sourcing this for research, remember that cyclosporin A is an approved drug in clinical contexts, but in laboratory research, it is strictly categorized as a peptide for experimental use only. Always ensure that your work adheres to the highest safety and ethical standards, focusing on the fascinating chemical properties of this unique cyclic structure rather than its medicinal applications.
By examining the cyclosporin sequence through the lens of modern biochemistry, we gain a deeper appreciation for how nature constructs such robust molecular scaffolds. It remains a hallmark example of how non-ribosomal peptide synthetases can produce highly specific, stable, and Mechanism of cyclosporin A biosynthesis. Evidence for functionally active macrocycles.